2023/24 will be somewhat gloomy
20/11/23 -"We have done a first round of data integration and adjustments to our figures as the annual report will be released in a few days. 2022/23 was helped by the better operating performance in Imaging ..."
Pages
74
Language
English
Published on
20/11/23
You may also be interested by these reports :
08/09/26
Medtech soared after Covid, then dropped out of sight until May 2026. Are its five lean years finally over? MedTech may have found a bottom Covid-era ...
07/09/26
We have revised our estimates upwards and removed the 20% discount previously applied to the peer-based valuation. This optimism is supported by ...
04/09/26
Bastide ended FY25/26 above its revenue target, with Q4 organic growth recovering as the VPH headwind faded, confirming the one-off nature of the ...
01/09/26
We have resumed our coverage of the Tecan Group, updating the company’s accounts and our forecasts. The share price has gained strong momentum since ...